Reduced exercise capacity in early-stage amyotrophic lateral sclerosis: Role of skeletal muscle

Alessandro Mezzani, Fabrizio Pisano, Alessandra Cavalli, Maria Antonietta Tommasi, Ugo Corr, Silvia Colombo, Bruno Grassi, Mauro Marzorati, Simone Porcelli, Lucia Morandi, Pantaleo Giannuzzi

Research output: Contribution to journalArticle

Abstract

Our objective was to correlate skeletal muscle mass (SM) with cardiopulmonary exercise testing (CPET) descriptors of exercise capacity in patients with amyotrophic lateral sclerosis (ALS) and compare ALS CPET data with those of patients with mitochondrial myopathy (MM) and normal subjects (N). Twenty-four early-stage ALS patients (63±11 years) underwent bioelectrical impedance analysis of body composition, resting spirometry, and ramp CPET. Six MM and six N were used as controls (56 ± 7 and 63 ± 4 years, respectively). Results showed that ALS SM index was similar to that of N (9.0±2.1 kg/m 2 vs. 10.4±1.9 kg/m 2, respectively; p = n.s.), whereas peak VO2/kg SM was significantly lower (41.5 ± 11.6 ml/kg/min vs. 57.8 ± 7.5 ml/kg/min, respectively; p <0.01). However, the heart rate/VO2 slope did not differ between ALS and N, being significantly higher in MM than in both ALS and N (6.1 ± 1.4 beats/ml/kg/min vs. 4.2 ± 1.1 beats/ml/kg/min vs. 3.8 ± 2.0 beats/ml/kg/min, respectively; both p <0.01), excluding a marked skeletal muscle metabolic impairment in ALS. Neither cardiovascular nor ventilatory dysfunction was detected in ALS. Early-stage ALS patients show a SM similar to N, but with a reduced peak VO2/kg SM. Such a reduced peripheral O2 utilization is consistent with deconditioning as the main cause of impaired exercise capacity in this population.

Original languageEnglish
Pages (from-to)87-94
Number of pages8
JournalAmyotrophic Lateral Sclerosis
Volume13
Issue number1
DOIs
Publication statusPublished - Jan 2012

Fingerprint

Amyotrophic Lateral Sclerosis
Skeletal Muscle
Exercise
Mitochondrial Myopathies
Architectural Accessibility
Spirometry
Body Composition
Electric Impedance
Heart Rate

Keywords

  • Amyotrophic lateral sclerosis
  • Muscle metabolism
  • Oxygen consumption
  • Skeletal muscle
  • Ventilation

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology

Cite this

Reduced exercise capacity in early-stage amyotrophic lateral sclerosis : Role of skeletal muscle. / Mezzani, Alessandro; Pisano, Fabrizio; Cavalli, Alessandra; Tommasi, Maria Antonietta; Corr, Ugo; Colombo, Silvia; Grassi, Bruno; Marzorati, Mauro; Porcelli, Simone; Morandi, Lucia; Giannuzzi, Pantaleo.

In: Amyotrophic Lateral Sclerosis, Vol. 13, No. 1, 01.2012, p. 87-94.

Research output: Contribution to journalArticle

Mezzani, A, Pisano, F, Cavalli, A, Tommasi, MA, Corr, U, Colombo, S, Grassi, B, Marzorati, M, Porcelli, S, Morandi, L & Giannuzzi, P 2012, 'Reduced exercise capacity in early-stage amyotrophic lateral sclerosis: Role of skeletal muscle', Amyotrophic Lateral Sclerosis, vol. 13, no. 1, pp. 87-94. https://doi.org/10.3109/17482968.2011.601463
Mezzani, Alessandro ; Pisano, Fabrizio ; Cavalli, Alessandra ; Tommasi, Maria Antonietta ; Corr, Ugo ; Colombo, Silvia ; Grassi, Bruno ; Marzorati, Mauro ; Porcelli, Simone ; Morandi, Lucia ; Giannuzzi, Pantaleo. / Reduced exercise capacity in early-stage amyotrophic lateral sclerosis : Role of skeletal muscle. In: Amyotrophic Lateral Sclerosis. 2012 ; Vol. 13, No. 1. pp. 87-94.
@article{576e329c64c1425b847e9a3da77456d0,
title = "Reduced exercise capacity in early-stage amyotrophic lateral sclerosis: Role of skeletal muscle",
abstract = "Our objective was to correlate skeletal muscle mass (SM) with cardiopulmonary exercise testing (CPET) descriptors of exercise capacity in patients with amyotrophic lateral sclerosis (ALS) and compare ALS CPET data with those of patients with mitochondrial myopathy (MM) and normal subjects (N). Twenty-four early-stage ALS patients (63±11 years) underwent bioelectrical impedance analysis of body composition, resting spirometry, and ramp CPET. Six MM and six N were used as controls (56 ± 7 and 63 ± 4 years, respectively). Results showed that ALS SM index was similar to that of N (9.0±2.1 kg/m 2 vs. 10.4±1.9 kg/m 2, respectively; p = n.s.), whereas peak VO2/kg SM was significantly lower (41.5 ± 11.6 ml/kg/min vs. 57.8 ± 7.5 ml/kg/min, respectively; p <0.01). However, the heart rate/VO2 slope did not differ between ALS and N, being significantly higher in MM than in both ALS and N (6.1 ± 1.4 beats/ml/kg/min vs. 4.2 ± 1.1 beats/ml/kg/min vs. 3.8 ± 2.0 beats/ml/kg/min, respectively; both p <0.01), excluding a marked skeletal muscle metabolic impairment in ALS. Neither cardiovascular nor ventilatory dysfunction was detected in ALS. Early-stage ALS patients show a SM similar to N, but with a reduced peak VO2/kg SM. Such a reduced peripheral O2 utilization is consistent with deconditioning as the main cause of impaired exercise capacity in this population.",
keywords = "Amyotrophic lateral sclerosis, Muscle metabolism, Oxygen consumption, Skeletal muscle, Ventilation",
author = "Alessandro Mezzani and Fabrizio Pisano and Alessandra Cavalli and Tommasi, {Maria Antonietta} and Ugo Corr and Silvia Colombo and Bruno Grassi and Mauro Marzorati and Simone Porcelli and Lucia Morandi and Pantaleo Giannuzzi",
year = "2012",
month = "1",
doi = "10.3109/17482968.2011.601463",
language = "English",
volume = "13",
pages = "87--94",
journal = "Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders",
issn = "1466-0822",
publisher = "Informa Healthcare",
number = "1",

}

TY - JOUR

T1 - Reduced exercise capacity in early-stage amyotrophic lateral sclerosis

T2 - Role of skeletal muscle

AU - Mezzani, Alessandro

AU - Pisano, Fabrizio

AU - Cavalli, Alessandra

AU - Tommasi, Maria Antonietta

AU - Corr, Ugo

AU - Colombo, Silvia

AU - Grassi, Bruno

AU - Marzorati, Mauro

AU - Porcelli, Simone

AU - Morandi, Lucia

AU - Giannuzzi, Pantaleo

PY - 2012/1

Y1 - 2012/1

N2 - Our objective was to correlate skeletal muscle mass (SM) with cardiopulmonary exercise testing (CPET) descriptors of exercise capacity in patients with amyotrophic lateral sclerosis (ALS) and compare ALS CPET data with those of patients with mitochondrial myopathy (MM) and normal subjects (N). Twenty-four early-stage ALS patients (63±11 years) underwent bioelectrical impedance analysis of body composition, resting spirometry, and ramp CPET. Six MM and six N were used as controls (56 ± 7 and 63 ± 4 years, respectively). Results showed that ALS SM index was similar to that of N (9.0±2.1 kg/m 2 vs. 10.4±1.9 kg/m 2, respectively; p = n.s.), whereas peak VO2/kg SM was significantly lower (41.5 ± 11.6 ml/kg/min vs. 57.8 ± 7.5 ml/kg/min, respectively; p <0.01). However, the heart rate/VO2 slope did not differ between ALS and N, being significantly higher in MM than in both ALS and N (6.1 ± 1.4 beats/ml/kg/min vs. 4.2 ± 1.1 beats/ml/kg/min vs. 3.8 ± 2.0 beats/ml/kg/min, respectively; both p <0.01), excluding a marked skeletal muscle metabolic impairment in ALS. Neither cardiovascular nor ventilatory dysfunction was detected in ALS. Early-stage ALS patients show a SM similar to N, but with a reduced peak VO2/kg SM. Such a reduced peripheral O2 utilization is consistent with deconditioning as the main cause of impaired exercise capacity in this population.

AB - Our objective was to correlate skeletal muscle mass (SM) with cardiopulmonary exercise testing (CPET) descriptors of exercise capacity in patients with amyotrophic lateral sclerosis (ALS) and compare ALS CPET data with those of patients with mitochondrial myopathy (MM) and normal subjects (N). Twenty-four early-stage ALS patients (63±11 years) underwent bioelectrical impedance analysis of body composition, resting spirometry, and ramp CPET. Six MM and six N were used as controls (56 ± 7 and 63 ± 4 years, respectively). Results showed that ALS SM index was similar to that of N (9.0±2.1 kg/m 2 vs. 10.4±1.9 kg/m 2, respectively; p = n.s.), whereas peak VO2/kg SM was significantly lower (41.5 ± 11.6 ml/kg/min vs. 57.8 ± 7.5 ml/kg/min, respectively; p <0.01). However, the heart rate/VO2 slope did not differ between ALS and N, being significantly higher in MM than in both ALS and N (6.1 ± 1.4 beats/ml/kg/min vs. 4.2 ± 1.1 beats/ml/kg/min vs. 3.8 ± 2.0 beats/ml/kg/min, respectively; both p <0.01), excluding a marked skeletal muscle metabolic impairment in ALS. Neither cardiovascular nor ventilatory dysfunction was detected in ALS. Early-stage ALS patients show a SM similar to N, but with a reduced peak VO2/kg SM. Such a reduced peripheral O2 utilization is consistent with deconditioning as the main cause of impaired exercise capacity in this population.

KW - Amyotrophic lateral sclerosis

KW - Muscle metabolism

KW - Oxygen consumption

KW - Skeletal muscle

KW - Ventilation

UR - http://www.scopus.com/inward/record.url?scp=84855393924&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84855393924&partnerID=8YFLogxK

U2 - 10.3109/17482968.2011.601463

DO - 10.3109/17482968.2011.601463

M3 - Article

C2 - 21830991

AN - SCOPUS:84855393924

VL - 13

SP - 87

EP - 94

JO - Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders

JF - Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders

SN - 1466-0822

IS - 1

ER -